Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassion
- Development stage
- Unknown
- Lead developer
- Acarpia Farmaceutici
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Potassion is an oral mineral supplement containing a balanced mixture of five potassium salts: potassium bicarbonate, potassium citrate, potassium malate, potassium succinate, and potassium tartrate. Developed and marketed by Acarpia Farmaceutici, it is indicated for the treatment of potassium deficiency (hypokalemia) and as an alkalizing therapy in conditions such as acidosis. By providing a highly bioavailable source of potassium ions (K+), Potassion helps restore hydrosaline balance, support normal muscle and neurological function, and regulate body fluids.
- Brand names
- Potassion
- Other names
- potassium bicarbonate + potassium citrate + potassium malate + potassium succinate + potassium tartratepotassium salts
Beyond the preview
Go deeper on Potassion.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Potassion.